See more : Whitecap Resources Inc. (SPGYF) Income Statement Analysis – Financial Results
Complete financial analysis of GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of GENOMIC VALLEY BIOTECH LIMITED, a leading company in the Biotechnology industry within the Healthcare sector.
- South Shore Holdings Limited (LOUIF) Income Statement Analysis – Financial Results
- Caissa Tosun Development Co., Ltd. (000796.SZ) Income Statement Analysis – Financial Results
- Cancom SE (CCCMF) Income Statement Analysis – Financial Results
- Beach Energy Limited (BCHEY) Income Statement Analysis – Financial Results
- Björn Borg AB (publ) (BORG.ST) Income Statement Analysis – Financial Results
GENOMIC VALLEY BIOTECH LIMITED (GVBL.BO)
About GENOMIC VALLEY BIOTECH LIMITED
Genomic Valley Biotech Ltd. operates as a development stage company. It engages in the floriculture business. The firm offers leases of ready-made greenhouses for farmers. It also researches about agriculture, stem cell, food biotechnology and environmental biotech product and process development. The company was founded on May 16, 1994 and is headquartered in Bahadurgarh, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.65M | 27.23M | 705.64K | 2.08M | 8.47M |
| Cost of Revenue | 0.00 | 15.86M | 24.49K | 1.30M | 153.92K |
| Gross Profit | 1.65M | 11.37M | 681.15K | 779.04K | 8.31M |
| Gross Profit Ratio | 100.00% | 41.75% | 96.53% | 37.44% | 98.18% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 1.50M | 1.92M | 1.01M | 1.77M |
| Selling & Marketing | 0.00 | 41.40K | 41.72K | 39.96K | 40.10K |
| SG&A | 375.00K | 1.54M | 1.96M | 1.05M | 1.81M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 375.00K | 5.30M | 1.05M | 4.01M | 4.79M |
| Cost & Expenses | 375.00K | 21.16M | 1.08M | 5.31M | 4.94M |
| Interest Income | 0.00 | 423.06K | 356.18K | 1.79M | 1.78M |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 10.93K | 79.24K | 840.87K | 1.89M | 1.79M |
| EBITDA | 147.40K | 8.79M | -3.72M | -1.34M | 5.62M |
| EBITDA Ratio | 8.93% | 32.28% | -527.69% | -64.44% | 66.39% |
| Operating Income | 1.28M | 8.71M | -4.56M | -3.23M | 3.83M |
| Operating Income Ratio | 77.28% | 31.99% | -646.85% | -155.37% | 45.29% |
| Total Other Income/Expenses | -1.12M | -3.34M | 1.27M | -1.79M | -1.78M |
| Income Before Tax | 151.48K | 6.49M | -16.49K | -5.02M | 2.06M |
| Income Before Tax Ratio | 9.18% | 23.83% | -2.34% | -241.16% | 24.30% |
| Income Tax Expense | 339.00 | 6.08K | 76.91K | 572.37K | 802.62K |
| Net Income | 151.82K | 6.48M | -93.40K | -5.59M | 2.86M |
| Net Income Ratio | 9.20% | 23.81% | -13.24% | -268.67% | 33.78% |
| EPS | 0.05 | 2.12 | -0.03 | -1.83 | 0.94 |
| EPS Diluted | 0.05 | 2.12 | -0.03 | -1.83 | 0.94 |
| Weighted Avg Shares Out | 3.04M | 3.06M | 3.11M | 3.05M | 3.04M |
| Weighted Avg Shares Out (Dil) | 3.04M | 3.06M | 3.11M | 3.05M | 3.04M |
Source: https://incomestatements.info
Category: Stock Reports